Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial

[1]  M. Koch,et al.  Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy , 2014, BMC Cancer.

[2]  R. Parks,et al.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. , 2013, The Lancet. Oncology.

[3]  R. Parks,et al.  Surgery for Colorectal Liver Metastases , 2013, Digestive Surgery.

[4]  M. Gonen,et al.  Comparison Between Perioperative and Postoperative Chemotherapy After Potentially Curative Hepatic Resection for Metastatic Colorectal Cancer , 2013, Annals of Surgical Oncology.

[5]  A. Eggermont,et al.  Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population‐based series , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[6]  Josep Tabernero,et al.  Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Colombo,et al.  Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases? , 2010, Annals of surgery.

[8]  A. Eggermont,et al.  Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases , 2010, The British journal of surgery.

[9]  E. Van Cutsem,et al.  Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. , 2009, The New England journal of medicine.

[10]  W. Hop,et al.  [Improvement of 5 year survival rate after liver resection for colorectal metastases between 1984-2006]. , 2009, Nederlands tijdschrift voor geneeskunde.

[11]  A. Eggermont,et al.  Local Treatment for Recurrent Colorectal Hepatic Metastases after Partial Hepatectomy , 2009, Journal of Gastrointestinal Surgery.

[12]  H. Saeger,et al.  Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[13]  N. Petrelli.  Perioperative or adjuvant therapy for resectable colorectal hepatic metastases. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[15]  P. Tekkis,et al.  Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer: A Multifactorial Model of 929 Patients , 2008, Annals of surgery.

[16]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Parks,et al.  Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. , 2007, Journal of the American College of Surgeons.

[18]  M. Makuuchi,et al.  Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. , 2007, Archives of surgery.

[19]  O. Garden,et al.  Prognostic scoring in colorectal cancer liver metastases: development and validation. , 2005, Archives of surgery.

[20]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.

[21]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[22]  T. Takada,et al.  A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. , 2004, Journal of hepato-biliary-pancreatic surgery.

[23]  Tom Mala,et al.  Hepatic resection for colorectal metastases: Can preoperative scoring predict patient outcome? , 2002, World Journal of Surgery.

[24]  D. Nitti,et al.  Patterns of Recurrence after Resection of Colorectal Liver Metastases: Prediction by Models of Outcome Analysis , 2001, World Journal of Surgery.

[25]  T. Starzl,et al.  Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. , 1999, Journal of the American College of Surgeons.

[26]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[27]  B. Nordlinger,et al.  Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.

[28]  S Bengmark,et al.  The natural history of primary and secondary malignant tumors of the liver I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy , 1969, Cancer.

[29]  N. Karanjia,et al.  Chemotherapy before liver resection of colorectal metastases: friend or foe? , 2015, Annals of surgery.

[30]  K. Uchiyama,et al.  Reconsideration of the Indications for Adjuvant Chemotherapy for Liver Metastases from Colorectal Cancer After Initial Hepatectomy , 2013, Annals of Surgical Oncology.

[31]  M. D'Angelica,et al.  Systemic Therapy for Patients with Resectable Hepatic Colorectal Metastases: Improving Patient Selection , 2013, Annals of Surgical Oncology.

[32]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[33]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[34]  H. Ueno,et al.  Indicators for treatment strategies of colorectal liver metastases. , 2000, Annals of Surgery.